Success Metrics

Clinical Success Rate
92.9%

Based on 39 completed trials

Completion Rate
93%(39/42)
Active Trials
25(27%)
Results Posted
13%(5 trials)
Terminated
3(3%)

Phase Distribution

Ph phase_1
2
2%
Ph phase_2
4
4%
Ph phase_4
3
3%
Ph early_phase_1
1
1%
Ph not_applicable
27
29%

Phase Distribution

3

Early Stage

4

Mid Stage

3

Late Stage

Phase Distribution37 total trials
Early Phase 1First-in-human
1(2.7%)
Phase 1Safety & dosage
2(5.4%)
Phase 2Efficacy & side effects
4(10.8%)
Phase 4Post-market surveillance
3(8.1%)
N/ANon-phased studies
27(73.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

81.3%

39 of 48 finished

Non-Completion Rate

18.8%

9 ended early

Currently Active

25

trials recruiting

Total Trials

92

all time

Status Distribution
Active(31)
Completed(39)
Terminated(9)
Other(13)

Detailed Status

Completed39
Recruiting15
unknown12
Active, not recruiting10
Withdrawn6
Enrolling by invitation3

Development Timeline

Analytics

Development Status

Total Trials
92
Active
25
Success Rate
92.9%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (2.7%)
Phase 12 (5.4%)
Phase 24 (10.8%)
Phase 43 (8.1%)
N/A27 (73.0%)

Trials by Status

enrolling_by_invitation33%
suspended11%
recruiting1516%
active_not_recruiting1011%
withdrawn67%
terminated33%
not_yet_recruiting33%
unknown1213%
completed3942%

Recent Activity

Clinical Trials (92)

Showing 20 of 92 trialsScroll for more
NCT06814990Not Applicable

Acquisition of Cardiac Function Parameters in MRI and Echocardiography in Patients With Ethyltoxic Liver Cirrhosis and Transjugular Intrahepatic Portosystemic Shunt (TIPSS) Placement

Recruiting
NCT05103852Not Applicable

Feasibility, Safety and Diagnostic Input of Interventional Cardiac MRI on a Series of 35 Patients With an Indication of Right Cardiac Catheterization.

Completed
NCT07670091Not Applicable

Endothelin Role In COronary Microcirculation

Active Not Recruiting
NCT04852731Not Applicable

STretch and Myocardial Characterization in Arrythmogenic Mitral Valve Prolapse-2

Active Not Recruiting
NCT05930418Not Applicable

Cardiovascular Magnetic Resonance Prognosticators in Pediatric Oncology Patients With Sepsis

Completed
NCT07650487

Perioperative Myocardial Injury in Patients Undergoing Coronary Artery Bypass Grafting: A Prospective Clinical Study

Not Yet Recruiting
NCT02747485Not Applicable

Impact of Diffuse Myocardial Fibrosis on the Ventricular Function in Regurgitant Left-Sided Valve Heart Diseases ( The DIFFUsE Study)

Active Not Recruiting
NCT07555925Not Applicable

RELIEVE METAB Study

Not Yet Recruiting
NCT07549477Not Applicable

A Study of Cardiac Magnetic Resonance Imaging (CMR) for Evaluating Catheter-Associated Right Atrial Clot in People With Cancer

Recruiting
NCT06770062

Multimodality Evaluation of Left Ventricular Remodeling In Mitral Regurgitation: A Pilot Study

Recruiting
NCT03498001Not Applicable

Effects of GLP-1 Agonists on CArdiac Steatosis Evaluated by Magnetic Resonance Imaging

Completed
NCT05164744

Cardiac Magnetic Resonance Tissue Characterization in COVID-19 Survivors

Recruiting
NCT03746964

Prospective Evaluation of the Biomechanical Properties of the Thoracic Aorta Coupling Magnetic Resonance Imaging and In-vitro Elasticity Tests in Patients With Ascending Aortic Aneurysm

Recruiting
NCT01671696

Defining Late Onset Occult Asymptomatic Cardiotoxicity in Childhood Cancer Survivors Exposed to Anthracycline Therapy

Completed
NCT07131631

Secondary Mitral Regurgitation Treatment With MitraClip and Assessment by Cardiac Magnetic Resonance

Recruiting
NCT06073574

CARDIO-TTRansform Magnetic Resonance Imaging (MRI) Sub-study

Active Not Recruiting
NCT02728336Not Applicable

MRI Assessment of Patient Suitability for Cardiac Resynchronization Therapy (CRT)

Suspended
NCT05558813Not Applicable

Natural History of Duchenne Muscular Dystrophy Cardiomyopathy (DMD-CMP)

Withdrawn
NCT04790266

Early Detection of Cardiotoxicity From Systemic and Radiation Therapy in Breast Cancer Patients

Completed
NCT02791581Not Applicable

Understanding and Predicting Breast Cancer Events After Treatment

Active Not Recruiting

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
92